Definitive Contract VA25816C0136
- Not listed
- This contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of Oncotype genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $114,305 Blanket Purchase Agreement (BPA) call covers a performance period through February 2026 and allows the VA to order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis. Genomic Health is also the prime...
- This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
- This is a $98,137.17 firm fixed-price delivery order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Genomic Health's Oncotype DX cancer diagnostic testing services, which analyze gene expression to determine cancer risk, recurrence potential, and treatment benefits. This delivery order falls under the Medical Laboratory Testing...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide reference lab testing services. The contract, valued at $228,525.24, was issued under the Medical Laboratory Testing and Analysis Services schedule and did not have a set-aside designation. Genomic Health has previously held multiple federal contracts with the Department of Defense and VA to deliver its...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...
- Genomic Health, Inc. was awarded a firm fixed price blanket purchase agreement call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 for $114,305 to provide Oncotype Genetic Testing Services from February 2024 through February 2028. The contract has no set-aside designation. Genomic Health will deliver its Oncotype DX portfolio of assays to support cancer screening, treatment selection, and disease monitoring programs at VA medical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $226,115.40 firm fixed price delivery order to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for Genomic Oncotype breast, colon, and prostate cancer testing services. This order was placed under Genomic Health's existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. Genomic Health has a history of providing cancer testing...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corp. The contract is for proprietary genetic testing services, specifically Genomic Health's Oncotype DX portfolio of cancer diagnostic assays, to support cancer screening, treatment selection, and disease monitoring for VHA patients. The contract has a potential value of $444,907.92 and a...
- This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of express cancer testing services, specifically Oncotype DX assays, to support the VA's healthcare programs. Genomic Health, as a provider of genomic-based cancer diagnostic tests, has received numerous prime and subcontractor awards from various federal agencies, including the...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price definitive contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide BREAST ONCOTYPING services. The contract has a potential value of $284,413.16 and a period of performance ending on September 30, 2022. Genomic Health, Inc. has provided cancer testing services, including its Oncotype DX portfolio of assays, to various Department of Defense and VA medical facilities under past...
This is a definitive contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype testing services for cancer. The $325,998.94 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 and does not have a set-aside designation. Genomic Health provides specialized genomic-based cancer diagnostic testing services, primarily focused on its Oncotype DX portfolio of tests that analyze gene expression to determine cancer risk, recurrence potential, and potential treatment benefits. The contract supports cancer screening, treatment selection, and disease monitoring programs across VA healthcare facilities. Genomic Health and its parent company Exact Sciences also hold several other indefinite delivery vehicle (IDV) contracts with federal agencies, including the Defense Health Agency and the U.S. Air Force, for a variety of cancer testing and diagnostic services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00015 | Funding Only Action | ($10k) | 6/30/21 | |
| P00014 | Supplemental Agreement for work within scope | ($10k) | 7/2/20 | |
| P00013 | Supplemental Agreement for work within scope | $10.0k | 10/1/19 | |
| P00012 | Supplemental Agreement for work within scope | ($5k) | 3/13/19 | |
| P00011 | Supplemental Agreement for work within scope | ($10k) | 3/7/19 |